I[ntegrins]{.smallcaps} are type I transmembrane αβ heterodimers that mediate cell adhesion and signaling in a highly regulated manner ([@B13]). Several modes of integrin regulation have been demonstrated or postulated, including control of expression on the cell surface by coordinate subunit biosynthesis and recycling ([@B6]; [@B8]), modulation of receptor affinity by conformational changes in the heterodimer ([@B60]; [@B57]), and modulation of receptor avidity by lateral diffusion of heterodimers to form higher order multimers or clusters ([@B17]; [@B63]; [@B38]; [@B5]). The latter process may be promoted by interactions of integrins with multivalent, extracellular ligands ([@B47]; [@B59]), and with components of the dynamic actin cytoskeleton ([@B50]; [@B22]; [@B38]). Integrin function must sometimes be regulated acutely over seconds to minutes to enable the kinds of rapid changes in cell adhesion and migration that are required during immune responses, inflammation, and hemostasis. Several integrins in blood cells are targets of this type of activation or "inside-out" signaling, including α~4~β~1~, α~L~β~2~, and α~M~β~2~ in leukocytes, and α~IIb~β~3~and α~V~β~3~ in platelets ([@B7]; [@B5]; [@B57]). It seems likely that some combination of conformational change and receptor clustering is involved in activating the ligand-binding function of these integrins. However, evidence to support one or the other mechanism has been largely indirect, and it has been difficult to determine the relative contributions of each in intact cells. The distinction between integrin affinity and avidity modulation is not academic because the underlying mechanisms may be different, with implications for therapeutic strategies to block or promote integrin functions in pathological conditions ([@B15]; [@B5]).

One of the best-studied integrins from the standpoint of acute regulation is α~IIb~β~3~, which interacts with Arg-Gly-Asp--containing ligands, such as fibrinogen and von Willebrand factor (vWf),^1^ to effect platelet aggregation and spreading on vascular surfaces. Platelet agonists, such as thrombin and ADP, cause rapid changes in the adhesive function of α~IIb~β~3~, as evidenced by increases in the binding of soluble fibrinogen, vWf, and ligand-mimetic mAbs, including PAC1 ([@B56]). Antagonists, such as prostacyclin and nitric oxide can inhibit and, under some conditions reverse these acute changes ([@B26]; [@B24]). Coupled with evidence from fluorescence resonance energy transfer studies showing that the α~IIb~ and β~3~ subunits undergo changes in relative orientation during platelet activation ([@B60]), a current hypothesis is that ligand binding to α~IIb~β~3~is controlled, at least in part, by changes in heterodimer conformation that affect access of the ligand to recognition sites in the receptor ([@B41]; [@B57]). On the other hand, it is entirely possible that clustering of α~IIb~β~3~also occurs during the process of platelet activation. Indeed, clustering of α~IIb~β~3~ on the platelet surface has been detected by electron microscopy after ligand binding ([@B33]; [@B59]). Were clustering to occur directly in response to platelet agonists, it could enhance ligand binding through chelate and rebinding effects. Furthermore, "outside-in" signaling through α~IIb~β~3~, manifested by activation of specific protein tyrosine kinases, lipid kinases, and cytoskeletal reorganization ([@B23]; [@B4]; [@B57]), seems to require the binding of multivalent ligands ([@B31]), indirectly suggesting a functional role for oligomerization of α~IIb~β~3~.

Since platelets are not amenable to genetic manipulations ex vivo, heterologous expression systems have been used to study the structure and function of α~IIb~β~3~ ([@B44]; [@B42]). For example, human α~IIb~β~3~ expressed in CHO cells binds little or no fibrinogen or PAC1 and is therefore, in a constitutively low affinity/ avidity state, just as it is in resting platelets. However, the affinity of α~IIb~β~3~ can be increased by incubation of the cells with particular "LIBS" mAb Fab fragments that bind to the α or β integrin subunit and induce a conformational change in the extracellular portion of the receptor to expose ligand binding sites ([@B44]). Under these experimental conditions, monovalent LIBS Fab fragments by themselves would not be expected to induce receptor clustering. In the present study, we have used new modifications of this experimental system to establish the separate contributions of affinity modulation and receptor clustering to the functions of α~IIb~β~3~. Specifically, single or tandem repeats of the FK506-binding protein, FKBP12 (FKBP), have been fused to the cytoplasmic tail of α~IIb~ to conditionally cluster heterodimers into oligomers from inside the cell using AP1510, a synthetic, bivalent, and membrane-permeable FKBP dimerizer ([@B3]). The results establish that affinity modulation and receptor clustering can play complementary roles in the adhesive and signaling functions of this prototypic integrin. Whereas affinity modulation is the predominant mechanism for regulating ligand binding to α~IIb~β~3~, receptor clustering facilitates this process and promotes outside-in signaling, even in the absence of affinity modulation.

Materials and Methods {#MaterialsMethods}
=====================

Plasmid Constructions and Expression of Recombinant Forms of α~IIb~β~3~ in CHO Cells
------------------------------------------------------------------------------------

A pCDM8 template containing full-length α~IIb~ ([@B44]) was subjected to PCR with *Pfu* polymerase (Stratagene, La Jolla, CA) to place XbaI and SpeI restriction sites at the 5′ and 3′ ends of α~IIb~, respectively. The PCR product was cut with XbaI and SpeI and ligated into an XbaI-cut, CMV-based mammalian expression vector, pCF1E (ARIAD Pharmaceutical, Inc., Cambridge, MA). Plasmids with inserts in the correct orientation were amplified and purified for CHO cell transfections (Maxi-Prep; QIAGEN Inc., Chatsworth, CA). The resulting α~IIb~(FKBP)/pCF1E plasmid encoded α~IIb~ fused in-frame to FKBP, which in turn was fused in-frame to a hemagglutinin epitope tag (see Fig. [1](#F1){ref-type="fig"}). To construct α~IIb~ fused to two tandem FKBP repeats (α~IIb~(FKBP)~2~), a single FKBP was removed from pCF1E with XbaI/SpeI and ligated into SpeI-cut α~IIb~(FKBP)/pCF1E. The remaining α~IIb~ and β~3~cDNAs depicted in Fig. [1](#F1){ref-type="fig"} were in pCDM8 ([@B44]). cDNA coding full-length human Syk was in EMCV ([@B25]). Plasmid inserts were analyzed by automated sequencing to confirm authenticity.

cDNAs were transfected into CHO-K1 cells with lipofectamine according to the manufacturer\'s instructions (GIBCO BRL, Gaithersburg, MD). Typically, 0.5--2 μg of each plasmid was used, supplemented when necessary with empty vector DNA (pCDNA3; Invitrogen, San Diego, CA) for a total of 4 μg per dish. Cells were maintained for 48 h for transient expression or subjected to antibiotic selection for stable expression. Stable cell lines were selected further for high integrin expression by single cell FACS^®^ sorting using an α~IIb~β~3~-specific murine mAb, D57 ([@B44]).

Characterization of Recombinant Integrins in CHO Cells
------------------------------------------------------

Cell surface expression of recombinant α~IIb~β~3~ was assessed by flow cytometry using biotin-D57 and FITC-streptavidin ([@B40]). α~IIb~ expression was also evaluated by Western blotting. 48 h after transfection, the cells were lysed in 66 mM Tris-HCl, pH 7.4, containing 2% SDS and 30 μg of protein were electrophoresed in SDS--7.5% polyacrylamide gels under nonreducing conditions, transferred to nitrocellulose, and then subjected to Western blotting with murine mAb B1B5 specific for α~IIb~ or antibody 12CA5 specific for the hemagglutinin epitope tag ([@B2]). After addition of affinity-purified, HRP-conjugated goat anti-- mouse IgG (Biosource International, Camarillo, CA), blots were developed for 0.1--1 min by enhanced chemiluminescence (ECL; Amersham, Arlington Heights, IL).

Confocal Microscopy
-------------------

To establish whether AP1510 could induce clustering of α~IIb~(FKBP)~2~β~3~ that was detectable morphologically, cells stably expressing α~IIb~(FKBP)~2~β~3~ were incubated in the presence of 1,000 nM AP1510 (or 0.5% EtOH as a vehicle control) for 30 min at room temperature. Then, analogous to the method used by Yauch and co-workers to detect antibody-induced integrin clustering ([@B68]), the cells were incubated with 10% goat serum for 30 min at room temperature, followed by 10 μM FITC-D57 or unlabeled D57 for 30 min on ice. After washing, the sample containing unlabeled D57 was incubated for 30 min with FITC-labeled goat anti--mouse heavy and light chains (1:500; Biosource International) to deliberately cluster the integrin as a positive control. All samples were fixed in 4% paraformaldehyde, resuspended in mounting medium (Fluorosave; Calbiochem-Novabiochem, San Diego, CA), and analyzed on glass slides with an MRC 1024 laser scanning confocal imaging system (Bio-Rad Laboratories, Hercules, CA).

Measurements of Ligand Binding Due to Clustering and Affinity Modulation of α~IIb~β~3~
--------------------------------------------------------------------------------------

Ligand binding to α~IIb~β~3~in CHO cells was assessed by flow cytometry using a saturating amount of the fibrinogen-mimetic, murine monoclonal IgMκ antibody, PAC1 ([@B35]). CHO cells were resuspended to 10^7^ cells/ml in Tyrode\'s buffer supplemented with 2 mM CaCl~2~and MgCl~2~ ([@B44]). For most experiments, 4 × 10^5^ cells were added to tubes containing a final concentration of 0.4% PAC1 ascites or 40 nM purified PAC1 in a final vol of 50 μl, and then incubated for 30 min at room temperature. In some experiments, monovalent recombinant PAC1 Fab produced in insect cells and purified by nickel-agarose chromatography was used instead of PAC1 IgM at a final concentration of 30 nM ([@B1]). As indicated for each experiment, cell incubations were also carried out in the presence of one or more of the following reagents: 10--5,000 nM AP1510 (or vehicle buffer) to cluster α~IIb~(FKBP)~2~β~3~or α~IIb~(FKBP)β~3~ ([@B3]), 150 μg/ml anti-LIBS6 Fab to convert α~IIb~β~3~ into a high affinity form through conformational changes ([@B20]; [@B35]), and 10 μM integrilin, an α~IIb~β~3~ antagonist to specifically block PAC1 binding ([@B54]). Preliminary experiments with AP1510 and anti--LIBS6 Fab indicated that a 10-- 30-min incubation of cells with these reagents was sufficient to achieve their maximum effects. Cells were then washed and incubated on ice for 30 min with biotin-D57, followed by phycoerythrin-streptavidin and either FITC-labeled goat anti--mouse μ heavy chain antibody (to label PAC1 IgM) or FITC-labeled goat anti--mouse heavy and light chain antibody (to label PAC1 Fab) (both from Biosource International). Samples were diluted with 0.5 ml Tyrode\'s buffer containing 2 μg/ml propidium iodide (Sigma Chemical Co., St. Louis, MO) and analyzed on a FACSCalibur^®^ flow cytometer (Becton Dickinson Co., Mountain View, CA). After electronic compensation, PAC1 binding (FL1 channel) was analyzed on the gated subset of live cells (propidium iodide--negative, FL3) that was positive for α~IIb~β~3~ expression (FL2). To control for variations in integrin expression from transfection to transfection, PAC1 binding, measured as mean fluorescence intensity in arbitrary units, was expressed relative to the levels of α~IIb~β~3~, measured simultaneously with biotin-D57.

Adhesion of CHO Cells to Fibrinogen and vWF
-------------------------------------------

Immulon-2 microtiter wells (Dynex Laboratories, Chantilly, VA) were coated with purified fibrinogen (Enzyme Research Laboratories, South Bend, IN) or vWf ([@B49]) overnight at 4°C at coating concentrations ranging from 0.01--2 μg/well, followed by blocking with 20 mg/ml BSA. CHO cells stably expressing α~IIb~(FKBP)~2~β~3~ were labeled for 30 min at 37°C with 2 μM BCECF-AM (Molecular Probes, Eugene, OR). After washing, the cells were resuspended to 10^6^/ml, incubated for 30 min in the presence of 1,000 nM AP1510 and/or 150 μg/ml anti--LIBS6 Fab, and then 100-μl aliquots were added to the coated microtitre wells for 90 min at 37°C. After washing three times with 150 μl of PBS, cell adhesion was quantitated by cytofluorimetry ([@B39]).

Protein Tyrosine Phosphorylation in CHO Cells
---------------------------------------------

Stable cell lines expressing α~IIb~(FKBP)~2~β~3~ were transiently transfected with EMCV-Syk and placed into complete DME with 10% FBS. 24 h after transfection, the amount of serum was reduced to 0.5%, and 48 h after transfection, the cells were resuspended to 3 × 10^6^/ml in DME and slowly rotated at 37°C for 45 min in the presence of 20 μM cycloheximide. Then cells were incubated for 10 min with one or more of the following: 1,000 nM AP1510 to stimulate receptor clustering, 150 μg/ml anti--LIBS6 Fab to increase integrin affinity, or 250 μg/ml fibrinogen to achieve ligand binding. As a positive tyrosine phosphorylation control, one aliquot of cells was allowed to attach for 60 min to a dish coated with α~IIb~β~3~ antibody D57. Cells were lysed in RIPA buffer containing 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 158 mM NaCl, 10 mM Tris, pH 7.4, 1 mM Na~2~EGTA, 0.5 mM leupeptin, 0.25 mg/ml Pefabloc, 5 μg/ml aprotinin, 20 mM NaF, 3 mM β-glycerophosphate, 10 mM sodium pyrophosphate, and 5 mM sodium vanadate. After clarification, 200 μg of protein were immunoprecipitated with rabbit antiserum specific for Syk or FAK ([@B25]). Immunoprecipitates were subjected to Western blotting with anti-phosphotyrosine mAbs, 4G10, and PY20 (Upstate Biotechnology Inc., Lake Placid, NY and Transduction Laboratories, Lexington, KY, respectively), followed by stripping and reprobing with mAb 4D10 to Syk or antiserum to FAK ([@B25]). Immunoreactive bands detected by ECL were quantitated by calibrated densitometry using a flatbed scanner, Power Center Pro 240 computer, and NIH Image software.

Results {#Results}
=======

Heterologous Expression of α~IIb~β~3~ Containing Dimerization Motifs
--------------------------------------------------------------------

The purpose of these studies was to evaluate the possible contributions of integrin clustering and affinity modulation to the adhesive and signaling functions of α~IIb~β~3~. A CHO cell model system, previously used to study factors that influence the ligand-binding affinity of human α~IIb~β~3~ ([@B44]; [@B32]; [@B69]; [@B35]), has now been adapted to study integrin clustering. Full-length α~IIb~ was engineered to contain one or two FKBP repeats and a hemagglutinin epitope tag at the extreme COOH terminus of the cytoplasmic tail (Fig. [1](#F1){ref-type="fig"}). In theory, a protein containing a single FKBP may dimerize upon addition of a membrane-permeable, bivalent FKBP ligand, such as AP1510, and a protein with two or more FKBP repeats may form larger oligomers ([@B3]; [@B67]; [@B66]). Consequently, we reasoned that if α~IIb~(FKBP) or α~IIb~(FKBP)~2~ were successfully coexpressed on the surface of CHO cells along with β~3~, then α~IIb~β~3~heterodimers might be converted into a dimer of dimers ((α~IIb~β~3~)~2~) or into even larger oligomers in response to AP1510.

After transient or stable expression in CHO cells, both α~IIb~(FKBP)β~3~ and α~IIb~(FKBP)~2~β~3~were found to be expressed to the same extent as wild-type α~IIb~β~3~, as determined by the binding of D57, an α~IIb~β~3~-specific antibody (Fig. [2](#F2){ref-type="fig"} *A*). In addition, Western blotting of the cell lysates with an antibody specific for the extracellular domain of α~IIb~ (B1B5) showed that α~IIb~(FKBP) and α~IIb~(FKBP)~2~ exhibited the predicted slower electrophoretic mobilities compared with the smaller wild-type α~IIb~ subunit (Fig. [2](#F2){ref-type="fig"} *B*). The α~IIb~(FKBP) and α~IIb~(FKBP)~2~ fusion proteins also reacted on Western blots with an antibody to the COOH-terminal epitope tag, further suggesting that they represented full-length proteins (Fig. [2](#F2){ref-type="fig"} *B*). Thus, the fusion of one or two FKBP repeats to the cytoplasmic tail of α~IIb~ does not interfere with the transient or stable expression of this subunit in CHO cells to form an α~IIb~β~3~ complex. Therefore, in the following studies transient and stable cell lines were used as indicated, depending on the experimental protocol.

Conditional Clustering of α~IIb~β~3~ in CHO Cells
-------------------------------------------------

Large integrin oligomers might be detectable in CHO cells at the level of light microscopy ([@B63]; [@B68]). To determine if clusters of α~IIb~(FKBP)~2~β~3~could be detected morphologically, CHO cells stably expressing †this integrin were incubated for 30 min at room temperature with 1,000 nM AP1510 (or vehicle buffer as a control), stained with FITC-D57 on ice, fixed, and then examined by confocal microscopy. D57 staining was entirely surface associated, and cells that had been treated with buffer instead of AP1510 exhibited a finely patchy distribution of α~IIb~(FKBP)~2~β~3~ (Fig. [3](#F3){ref-type="fig"}, *A--C*). In contrast, α~IIb~(FKBP)~2~β~3~ in cells treated with AP1510 exhibited a coarse patchiness (Fig. [3](#F3){ref-type="fig"}, *E--G*), similar to that observed when the D57 antibody was deliberately cross-linked with a secondary antibody before cell fixation (Fig. [3](#F3){ref-type="fig"} *H*). The same results with AP1510 were obtained with another independent α~IIb~(FKBP)~2~β~3~ clone; in contrast, AP1510 caused no discernible clustering of wild-type α~IIb~β~3~ in CHO cells (not shown). These results are consistent with the conclusion that oligomerization of α~IIb~(FKBP)~2~β~3~can be induced conditionally from within the cell using AP1510, enabling us to conduct a detailed study of the functional consequences of integrin clustering.

Receptor Clustering in the Regulation of Ligand Binding to α~IIb~β~3~
---------------------------------------------------------------------

Activation of α~IIb~β~3~is required for the binding of soluble, macromolecular Arg-Gly-Asp--containing ligands, such as fibrinogen, vWf, and fibrinogen-mimetic antibodies, such as PAC1. To evaluate the contribution of clustering to α~IIb~β~3~ activation, flow cytometry was used to quantitate the specific binding of PAC1 to transiently transfected CHO cells. Specific binding was defined as that inhibitable by 10 μM integrilin, an α~IIb~β~3~-selective antagonist, and it was expressed relative to the amount of α~IIb~β~3~ on the cell surface, determined simultaneously with antibody D57. In cells expressing α~IIb~(FKBP)~2~β~3~, there was little binding of PAC1, indicating that, like α~IIb~β~3~, this integrin is in a constitutive low affinity/avidity state. AP1510 caused a dose-dependent increase in PAC1 binding to α~IIb~(FKBP)~2~β~3~ cells (Fig. [4](#F4){ref-type="fig"}, *closed circles*), without affecting the levels of surface expression of this integrin. However, PAC1 binding due to AP1510 appeared modest compared with binding in response to upregulation of integrin affinity by an activating antibody Fab fragment, anti--LIBS6 Fab (Fig. [4](#F4){ref-type="fig"}, *open circles*).

To evaluate possible mechanistic differences between integrin clustering and affinity modulation in the control of ligand binding, additional experiments were performed with cells expressing α~IIb~(FKBP)~2~β~3~. First, we considered the possibility that AP1510 caused PAC1 binding by increasing integrin affinity rather than (or in addition to) avidity. However, AP1510 failed to stimulate the binding of a monovalent PAC1 Fab fragment to α~IIb~(FKBP)~2~β~3~, although this form of PAC1 bound normally in response to anti--LIBS6 Fab (Fig. [5](#F5){ref-type="fig"}). Since a monovalent ligand might be expected to be sensitive to affinity modulation but less sensitive than a multivalent ligand to avidity modulation, this result suggests that AP1510 was indeed working by clustering the integrin. Second, PAC1 binding in response to AP1510 was completely prevented if the cells were preincubated for 30 min with 4 mg/ml of 2-deoxy-[d]{.smallcaps}-glucose and 0.2% sodium azide to deplete metabolic ATP (two separate experiments). Since oligomerization by AP1510 should be energy independent, this suggests that metabolic energy is needed to maintain the receptor in a proper conformation, even when ligand binding is triggered by receptor clustering. Third, the effect of a specific point mutation (β~3~(S752P)) or a truncation (β~3~(Δ724)) of the β~3~cytoplasmic tail were studied because both have been shown to disrupt affinity modulation of α~IIb~β~3~ in platelets and CHO cells ([@B10], [@B11]; [@B44]; [@B64]). Whereas β~3~(S752P) abolished PAC1 binding in response to AP1510, β~3~(Δ724) had no such effect (Fig. [6](#F6){ref-type="fig"}). Thus the β~3~ cytoplasmic tail plays a role in ligand binding triggered by integrin clustering, but there must be differences in the structural features of β~3~ required for affinity and avidity modulation.

Thus far, the results support the validity of this model system to study integrin clustering, and they suggest that both clustering and affinity modulation can regulate ligand binding to α~IIb~β~3~. Further studies were performed to determine the relative contributions of clustering and affinity modulation to ligand binding under conditions in which the effects of AP1510 and anti--LIB6 Fab were maximal (1,000 nM and 150 μg/ml, respectively). CHO cells were transiently transfected with either α~IIb~β~3~, α~IIb~(FKBP)β~3~, α~IIb~(FKBP)~2~β~3~, or α~IIb/~α~6A~β~3~ (a constitutive, high affinity mutant \[[@B44]\]), and ligand binding was evaluated 48 h later. Whereas AP1510 had no effect on PAC1 binding to wild-type α~IIb~β~3~, it increased binding to both α~IIb~(FKBP)β~3~and α~IIb~(FKBP)~2~β~3~ such that specific PAC1 binding was increased approximately twofold (*P* \< 0.001) (Fig. [7](#F7){ref-type="fig"}). However, PAC1 binding induced by AP1510 amounted to only 50% of the binding observed with the high affinity α~IIb~/α~6A~β~3~ chimera, and only 25% of the binding induced by anti--LIBS6 Fab (Fig. [7](#F7){ref-type="fig"}). Nevertheless, the PAC1 binding caused by clustering was statistically significant (*P* \< 0.03) and approximately additive to the binding caused by affinity modulation (Fig. [7](#F7){ref-type="fig"}).

Fibrinogen and PAC1 binding to activated platelets is initially reversible by the addition of EDTA, but binding becomes progressively irreversible over 15--60 min ([@B46]; [@B22]). In CHO cells that expressed α~IIb~(FKBP)~2~β~3~ and were treated with both anti--LIBS6 Fab and AP1510 to achieve maximal PAC1 binding, the added component of ligand binding resulting from AP1510 was fully reversible at 10 min but irreversible at 30 min (Fig. [8](#F8){ref-type="fig"}). Similar results were obtained when FITC-fibrinogen was used instead of PAC1 to monitor ligand binding (not shown). This series of experiments demonstrates that affinity modulation is the predominant regulator of ligand binding to α~IIb~β~3~. However, receptor clustering plays an additive role in promoting eventual irreversible binding of the ligand.

α~IIb~β~3~Clustering in the Regulation of Cell Adhesion
-------------------------------------------------------

Activation of platelets by agonists leads to increased cell adhesion to the α~IIb~β~3~ligands, fibrinogen, and vWf ([@B52]). To determine the relative contributions of α~IIb~β~3~ clustering and affinity modulation to cell adhesion, CHO cells that stably expressed α~IIb~(FKBP)~2~β~3~were loaded with BCECF as a fluorescent marker and incubated for 90 min in microtiter wells coated with fibrinogen or vWf. Cell adhesion was dependent on the coating concentration of fibrinogen (Fig. [9](#F9){ref-type="fig"}, *left panel*  ) and vWf (Fig. [9](#F9){ref-type="fig"}, *right panel*  ), as well as on the presence of α~IIb~(FKBP)~2~β~3~, since it was blocked by 10 μM integrilin. AP1510 (1,000 nM) increased the extent of cell adhesion, but only very modestly and only at the higher coating concentrations of fibrinogen and vWf. On the other hand, increasing integrin affinity with anti--LIBS6 Fab (150 μg/ml) caused a more marked increase in cell adhesion, even at the lower ligand concentrations (Fig. [9](#F9){ref-type="fig"}, *left* and *right panels*). Thus under these assay conditions, receptor clustering is not as effective as affinity modulation in regulating cell adhesion via α~IIb~β~3~.

α~IIb~β~3~ Clustering in the Regulation of Outside-In Signaling
---------------------------------------------------------------

In platelets and CHO cell transfectants, fibrinogen binding to α~IIb~β~3~leads to tyrosine phosphorylation and activation of Syk and FAK. The binding of soluble fibrinogen is sufficient to activate Syk, but additional post--ligand binding events, such as cytoskeletal reorganization, are necessary for activation of FAK ([@B31]; [@B14]; [@B25]). To study the role of integrin clustering in these events, CHO cells stably expressing α~IIb~(FKBP)~2~β~3~ were transiently-transfected with human Syk, and tyrosine phosphorylation of Syk and endogenous hamster FAK was examined. Fig. [10](#F10){ref-type="fig"} *A* shows the raw data for a single experiment and Fig. [10](#F10){ref-type="fig"} *B* shows a summary of three separate experiments. Cells maintained in suspension for 10 min in the absence or presence of fibrinogen exhibited a low level of tyrosine phosphorylation of Syk and FAK. However, addition of 1,000 nM AP1510 caused an average 2.8-fold increase in tyrosine phosphorylation of Syk, even in the absence of fibrinogen (*P* \< 0.05), and this response was greater still in the presence of fibrinogen (5.4-fold; *P* \< 0.02). In contrast, in the absence of fibrinogen integrin clustering by AP1510 did not stimulate an increase in FAK tyrosine phosphorylation, but increased FAK phosphorylation was observed in the presence of fibrinogen (3.5-fold; *P* \< 0.001). Thus, integrin clustering can trigger tyrosine phosphorylation of Syk even in the absence of fibrinogen binding, whereas phosphorylation of FAK requires both receptor clustering and fibrinogen binding. Affinity modulation by anti-LIBS6 is not necessary in either case.

Discussion {#Discussion}
==========

In this study, engraftment of one or two FKBP repeats onto the COOH terminus of the α~IIb~ subunit enabled us to cluster integrin α~IIb~β~3~ in a conditional fashion by treating CHO cells with a synthetic, bivalent FKBP ligand, AP1510. This permitted us for the first time to conduct a detailed comparison of the functional effects of receptor clustering, initiated from within the cell, with the effects of increasing integrin affinity through conformational changes. The major conclusions of this work are: (*a*) Conformational changes play a predominant role in α~IIb~β~3~ activation in CHO cells, as monitored by ligand binding and cell adhesion assays. (*b*) Clustering causes a modest increment in reversible and ultimately irreversible binding of multivalent ligands to α~IIb~β~3~, and this binding is additive to that caused by affinity modulation. (*c*) Ligand binding resulting from receptor clustering is dependent on cellular metabolic energy and is sensitive to some, but not all, of the mutations or deletions in the β~3~ cytoplasmic tail that block affinity modulation of the receptor. (*d*) Integrin clustering promotes ligand-independent tyrosine phosphorylation of Syk, and ligand- dependent phosphorylation of FAK, even when cells are maintained in suspension and even in the absence of deliberate affinity modulation. Thus, by being able to manipulate integrin clustering and affinity separately and in a controlled manner, we conclude that these two processes play complementary roles in the function of α~IIb~β~3~.

Integrin Clustering and Inside-Out Signaling
--------------------------------------------

Inside-out signaling is responsible for acute regulation of the ligand binding function of integrins. In the case of integrins that normally engage soluble adhesive ligands in vivo, such as α~IIb~β~3~, inside-out signaling can be monitored directly using labeled ligands or ligand-mimetic antibodies, such as PAC1. Alternatively, it can be assessed by cell adhesion assays. Although physiologically relevant, cell adhesion is a more indirect measure of integrin activation because it can be influenced by factors, such as actin polymerization, cell spreading, and focal adhesion turnover, that may affect the overall strength of the adhesion process through mechanisms other than regulation of ligand binding ([@B9]; [@B65]; [@B28]). Thus, when possible, it is preferable to monitor inside-out signaling by ligand binding assays, as in the current study.

Ligand binding to integrins is thought to be regulated by a combination of affinity and avidity modulation ([@B62]; [@B18]; [@B5]). In the case of α~IIb~β~3~, platelet activation is believed to cause a modification of the conformation or orientation of the integrin cytoplasmic tails that is transmitted across the membrane, leading to increased access of the ligand to binding sites in the receptor ([@B41]; [@B57]). However, cell activation appears to promote ligand binding to certain β~1~ and β~2~ integrins by also stimulating the lateral diffusion and clustering of these receptors ([@B62]; [@B38]; [@B5]; [@B57]), and the same might be true for α~IIb~β~3~. Several experimental approaches have been used to cluster integrins, including treatment of cells with multivalent antibodies or chemical cross-linkers, incubation of cells with ligand-coated beads, and promotion of cell spreading ([@B37]; [@B19]; [@B30]; [@B43]). Whereas each of these has provided important information about outside-in signaling, none is entirely suitable for studies of soluble ligand binding to α~IIb~β~3~. The use here of AP1510 to cluster α~IIb~(FKBP)β~3~ or α~IIb~(FKBP)~2~β~3~, while CHO cells were maintained in suspension demonstrates unambiguously that affinity and avidity modulation can complement one another with respect to the control of ligand binding. Given the wide variety of soluble, matrix- and cell-associated ligands that integrins must contend with, it is likely that the relative contributions of affinity and avidity modulation will vary with the integrin and the cell type.

Fortunately, the fusion of single or tandem FKBP repeats to the α~IIb~ cytoplasmic tail did not interfere with α~IIb~β~3~ expression or function in CHO cells. Perhaps this means that the very COOH terminus of the α subunit is dispensable for the integrin functions that were assessed. On the other hand, direct attachment of FKBP to the β~3~ tail interferes with energy-dependent affinity modulation of α~IIb~β~3~, possibly by disrupting necessary interactions of the β~3~tail with regulatory proteins (Hato, T., and Shattil, S.J., unpublished observations). We ascribe any functional effects of AP1510 on α~IIb~(FKBP)β~3~ and α~IIb~(FKBP)~2~β~3~to receptor clustering. Although the evidence for this is strong, it is largely indirect. First, AP1510 only affected those forms of α~IIb~β~3~ that contained FKBP repeats (Figs. [6](#F6){ref-type="fig"} and [7](#F7){ref-type="fig"}). Second, confocal microscopy showed that AP1510 treatment was associated with the appearance of coarse patches of integrin staining in the surface membrane (Fig. [3](#F3){ref-type="fig"}). Finally, AP1510 caused binding of a multivalent but not monovalent form of PAC1, precisely what might be expected in the case of integrin clustering (Fig. [5](#F5){ref-type="fig"}). Interestingly, the effect of AP1510 on PAC1 binding to α~IIb~(FKBP)β~3~ and α~IIb~(FKBP)~2~β~3~was nearly equivalent (Fig. [7](#F7){ref-type="fig"}). Assuming that AP1510 can only dimerize α~IIb~(FKBP)β~3~, this suggests that formation of a dimer of dimers, e.g., (α~IIb~(FKBP)β~3~)~2~, may be sufficient to initiate some ligand binding to α~IIb~β~3~.

What are the biological implications of α~IIb~β~3~ clustering during inside-out signaling? Ligand binding resulting from clustering of α~IIb~(FKBP)~2~β~3~ required a normal β~3~ cytoplasmic tail since a tail point mutation (S752P) disrupted this process (Fig. [6](#F6){ref-type="fig"}). This same mutation disrupts energy- dependent affinity modulation of α~IIb~β~3~ in CHO cells and in human platelets, where it is responsible for a bleeding diathesis ([@B10], [@B11]). In contrast, another β~3~ cytoplasmic modification, a truncation starting at residue Arg 724, did not disrupt ligand binding induced by clustering of α~IIb~(FKBP)~2~β~3~, although it does abolish affinity modulation of α~IIb~β~3~in CHO cells and platelets ([@B44]; [@B64]). This suggests that there are differences in the structural elements of the β~3~ tail that are needed for affinity and avidity modulation. A growing number of proteins have been shown to interact directly with the cytoplasmic tails of α or β integrin subunits, at least in vitro, and overexpression of some of them, including calreticulin (α tails) ([@B16]), cytohesin-1 (β~2~ tail) ([@B36]), and β~3~-endonexin (β~3~ tail) ([@B35]) can affect ligand binding and cell adhesion. When overexpressed in CHO cells, several other signaling proteins, including H-ras ([@B32]), R-ras ([@B69]), and CD98 ([@B21]) have been shown to modulate the ligand binding properties of α~IIb~β~3~; however, it is not known if any of these proteins interact directly with the integrin. The relative effects of potential regulatory molecules such as these on receptor clustering and receptor affinity remain to be determined.

The extent of PAC1 binding observed in response to integrin clustering was only a fraction of that observed with affinity modulation. Yet ligand binding resulting from clustering and affinity modulation was additive (Fig. [7](#F7){ref-type="fig"}). Clustering also facilitated CHO cell adhesion to immobilized fibrinogen and vWf, but once again, this effect was relatively minor compared with the effect of affinity modulation and it was apparent only at the higher coating concentrations of the ligands (Fig. [9](#F9){ref-type="fig"}). On the other hand, if clustering of α~IIb~β~3~were to cause increased ligand binding in platelets as it does in CHO cells, it could affect the ultimate size of a platelet aggregate and hence the delicate balance between adequate and inadequate hemostasis or the difference between partial and total arterial occlusion by a platelet-rich thrombus. Conceivably, the effects of integrin clustering on ligand binding may be even more pronounced in platelets than in the CHO cell model system because receptor density may be higher in platelets and clustering may be stimulated by agonists that trigger integrin interactions with multivalent, polymerizing ligands on both sides of the plasma membrane ([@B29]; [@B22]; [@B58]). Furthermore, any increase in adhesive strength promoted by α~IIb~β~3~ clustering in vivo might help platelets resist detachment from sites of vascular injury in response to hemodynamic forces ([@B53]).

Integrin Clustering and Outside-In Signaling
--------------------------------------------

A potential limitation of the chemical dimerization approach used here is that it may not reflect or trigger the types of interactions between α~IIb~β~3~, cytoskeletal proteins, and signaling molecules that take place normally during outside-in signaling. For example, in platelets, the binding of fibrinogen to α~IIb~β~3~ is sufficient to trigger tyrosine phosphorylation and activation of Syk, whereas tyrosine phosphorylation of FAK requires additional post--ligand binding events that occur during platelet aggregation or spreading ([@B27]; [@B31]). In this regard, clustering of α~IIb~(FKBP)~2~β~3~ in CHO cells by AP1510 caused significant tyrosine phosphorylation of Syk, even when the cells were maintained in suspension without fibrinogen (Fig. [10](#F10){ref-type="fig"}). Since integrin-dependent tyrosine phosphorylation of Syk correlates with induction of Syk kinase activity in both platelets and CHO cells ([@B14]; [@B25]), these results suggest that the binding of multivalent fibrinogen to α~IIb~β~3~triggers Syk activation, at least in part, by inducing integrin clustering.

In contrast to the results for Syk, clustering of α~IIb~(FKBP)~2~β~3~by AP1510 was not sufficient to cause tyrosine phosphorylation of FAK in cells maintained in suspension. However, fibrinogen binding together with receptor clustering were sufficient to induce the response (Fig. [10](#F10){ref-type="fig"}). These results highlight the apparent differences in coupling mechanisms between α~IIb~β~3~ and Syk and α~IIb~β~3~and FAK ([@B25]). At the same time, they demonstrate unambiguously that conditional clustering of α~IIb~β~3~in CHO cells can recapitulate a pattern of outside-in signaling that is characteristic of platelets. In nucleated cells, integrin and growth factor signaling pathways collaborate to regulate gene expression, cell adhesion, and motility ([@B55]; [@B34]; [@B51]; [@B65]). One hallmark of integrated signaling networks is tight control of enzyme activity and protein subcellular localization though regulated protein--protein interactions ([@B45]). Chemical inducers of dimerization can be used to promote controlled homodimerization and heterodimerization of proteins in vivo as well as ex vivo ([@B48]; [@B61]; [@B12]; [@B66]). Consequently, they should prove useful in evaluating diverse aspects of integrin signaling.
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ECL

:   enhanced chemiluminescence

FKBP

:   FK506 binding protein, or FKBP12

vWf

:   von Willebrand factor

![Integrin constructs used in this study. The vertical bar represents the cell membrane. Integrin extracellular domains are to the left of the bar and intracellular domains to the right. The relative sizes of the various domains are not drawn to scale. For example, the cytoplasmic tail of α~IIb~ contains 20 amino acid residues and a single FKBP repeat contains ∼100 residues. The asterisk in β~3~(S752P) marks the site of the point mutation.](JCB9803100.f1){#F1}

###### 

Expression of α~IIb~(FKBP) fusion constructs with β~3~ in CHO cells. In *A*, cells were transiently or stably transfected with the indicated integrin subunits and stained with a combination of the anti-α~IIb~β~3~ mAb, biotin-D57, and FITC-streptavidin for assessment of integrin surface expression by flow cytometry. One sample of cells was mock transfected to serve as a negative control in the transient transfections, and untransfected CHO cells served as a negative control for the stable transfectants. In *B*, cells were transiently transfected with the indicated integrin constructs. 48 h later, the cells were lysed with SDS sample buffer and 30 μg of protein were subjected to Western blotting with an mAb to α~IIb~ (B1B5) or antibody 12CA5 to the hemagglutinin epitope tag located at the COOH terminus of α~IIb~(FKBP) and α~IIb~(FKBP)~2~. Brackets indicate the region on each blot where the different forms of α~IIb~ are located. The very light band seen in the CHO cell lane on the B1B5 blot was neither consistent nor specific. In this particular experiment, the level of expression of α~IIb~(FKBP)~2~β~3~was less than that of α~IIb~(FKBP)β~3~, accounting for the difference in band intensities between the two samples.

![](JCB9803100.f2a)

![](JCB9803100.f2b)

![Distribution of α~IIb~(FKBP)~2~β~3~ in CHO cells. CHO cells stably expressing α~IIb~(FKBP)~2~β~3~ were incubated in suspension for 30 min in the absence (*A--D*, and *H*) or presence (*E--G*) of 1,000 nM AP1510. They were then incubated at 4°C with FITC-D57 to stain the integrin (*A--C*, and *E--G*), fixed, and then deposited onto glass slides for confocal microscopy. As a negative control, cells in *D* were incubated only with FITC goat anti--mouse immunoglobulin. As a positive control, cells in *H* were incubated with unlabeled D57, followed by FITC goat anti--mouse immunoglobulin to deliberately cross-link the integrin before fixation. Panels represent single images collected from the entire series of 0.5-μm focal planes. Images are from a single experiment representative of four so performed. Bar, 10 μm.](JCB9803100.f3){#F3}

![Effect of the dimerizer, AP1510, and the activating antibody, anti--LIBS6 Fab, on PAC1 binding to CHO cells expressing α~IIb~(FKBP)~2~β~3~. Cells were transfected with α~IIb~(FKBP)~2~ and β~3~. After 48 h, they were incubated for 30 min with PAC1 along with AP1510 and/or 150 μg/ml anti-LIBS6. Then PAC1 binding to α~IIb~(FKBP)~2~β~3~-expressing cells was quantitated by flow cytometry as described in Materials and Methods. Specific PAC1 binding was defined as binding inhibitable by 10 μM integrilin, a selective α~IIb~β~3~ antagonist. It was expressed relative to the amount of integrin per cell determined simultaneously with antibody D57.](JCB9803100.f4){#F4}

![Relative effects of α~IIb~β~3~ clustering and affinity modulation on the binding of multivalent PAC1 IgM and monovalent PAC1 Fab to CHO cells. Cells stably expressing α~IIb~(FKBP)~2~β~3~were incubated with a saturating concentration of PAC1 IgM (40 nM) or recombinant PAC1 Fab (30 nM) for 30 min in the absence or presence of AP1510, and specific binding of PAC1 was quantitated by flow cytometry. Unlike most other experiments, PAC1 was expressed here simply as mean fluorescence intensity in arbitrary units since correction for the degree of integrin expression was not necessary. Data represent the means ± SD of triplicate values from one experiment representative of two so performed.](JCB9803100.f5){#F5}

![Effects of β~3~ cytoplasmic tail mutations on PAC1 binding caused by receptor clustering and affinity modulation. CHO cells were transiently transfected with the indicated α~IIb~ and β~3~ subunits. 48 h later, they were incubated for 30 min with PAC1 along with AP1510 and/or 150 μg/ml anti--LIBS6 Fab, and specific PAC1 binding was quantitated by flow cytometry. Note the almost 10-fold difference in scales of the y axes. Data represent the means ± SEM of three experiments.](JCB9803100.f6){#F6}

![Relative effects of receptor clustering and affinity modulation on PAC1 binding to α~IIb~β~3~. CHO cells were transiently transfected with the indicated integrin constructs. 48 h later, they were incubated for 30 min with PAC1 along with AP1510 and/or 150 μg/ml anti--LIBS6 Fab, and specific PAC1 binding was quantitated by flow cytometry. Note the difference in scales of the y axes. Data represent the means ± SEM of three to five experiments.](JCB9803100.f7){#F7}

![Effect of receptor clustering on reversible and irreversible ligand binding to α~IIb~(FKBP)~2~β~3~. Binding of PAC1 in response to anti--LIBS6 Fab was initiated in CHO cells stably- expressing α~IIb~(FKBP)~2~β3, either in the absence or presence of AP1510. After 10 or 30 min, half of each sample was treated with 5 mM EDTA to displace reversibly bound PAC1 and half was not. Then specific PAC1 binding was determined. Reversible PAC1 binding was defined as specific binding displaced by EDTA, and irreversible binding was defined as specific binding that was not displaced by EDTA. Data represent the means ± SEM of three experiments.](JCB9803100.f8){#F8}

![Relative effects of receptor clustering and affinity modulation on CHO cell adhesion to fibrinogen or vWF. As described in Materials and Methods, CHO cells stably expressing α~IIb~(FKBP)~2~β~3~ were fluorescently labeled with BCECF, and then incubated for 90 min in microtiter wells coated with fibrinogen (*left panel* ) or vWf (*right panel* ) in the presence of 1,000 nM AP1510 and/or 150 μg/ml anti--LIBS6 Fab. After washing, cell adhesion was quantitated by cytofluorimetry. Adhesion was expressed as a percentage of total cells added. This experiment is representative of three so performed. Not shown is the fact that in the absence of AP1510, the adhesion of α~IIb~(FKBP)~2~β~3~ cells was the same as for cells expressing wild-type α~IIb~β~3~.](JCB9803100.f9){#F9}

###### 

Effect of integrin clustering on tyrosine phosphorylation of Syk and FAK. In *A*, CHO cells stably-expressing α~IIb~(FKBP)~2~β~3~ were transiently transfected with Syk. 48 h later, they were incubated in suspension for 10 min as indicated with 1,000 nM AP1510, 150 μg/ml anti--LIBS6 Fab, and/or 250 μg/ml fibrinogen. Lysates were prepared and immunoprecipitated with rabbit antiserum to Syk (*top*) or FAK (*bottom*), and samples were subjected to Western blotting with antibodies 4G10 and PY20 to phosphotyrosine (*anti--P-Tyr*). Finally, blots were stripped and reprobed with antibodies to Syk or FAK to assess gel loading. The first lane in each blot is a negative control using normal rabbit serum (*NRS*) for immunoprecipitation. The last lane (*Adh*) is a "positive control" in which cells were allowed to become adherent over 60 min to immobilized antibody D57 before lysis. In *B*, the data represent the means ± SEM of three such experiments. The intensities of the phosphotyrosine bands are expressed relative to the intensities of the matching Syk and FAK immunoreactive bands. Asterisks denote statistically significant differences (*P* ≤ 0.05) from the cells incubated in suspension without additives (*black bar* labeled --).
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